Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4220

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 70518-4220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Rosuvastatin calcium 40 mg film-coated tablets, quantity 90, manufactured by Glenmark and repackaged by RemedyRepack Inc. The label includes the product's NDC, storage instructions (20-25°C with excursions allowed to 15-30°C), and a note to see the package insert for directions for use. It also advises keeping the medication out of reach of children.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A Kaplan-Meier curve showing cumulative incidence percentage over 5 years comparing placebo and Rosuvastatin calcium (R SUV). The graph displays a lower cumulative incidence for Rosuvastatin compared to placebo. A hazard ratio of 0.56 with 95% confidence interval 0.46-0.69 and P-value <0.001 is noted. The number at risk for both groups declines over time as detailed below the x-axis.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A data table and forest plot showing number of events for Rosuvastatin calcium 20 mg versus placebo 20 mg groups for various cardiovascular endpoints, including primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. The table lists event rates per 1000-patient years, hazard ratios with 95% confidence intervals, and p-values alongside a visual hazard ratio plot.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
Box plot chart depicting the percent change from baseline in LDL-C levels for four statin drugs—Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin—across various doses. The x-axis shows drug names and corresponding doses in mg, while the y-axis represents percent change from baseline in LDL-C, ranging from 0 to -75 percent.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of rosuvastatin calcium, showing the molecular arrangement including sulfonamide, fluorophenyl, and hydroxyl groups, along with the calcium ion complex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.